Published in Mov Disord on January 01, 1998
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A (2008) 2.64
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci (2009) 2.29
Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol (2007) 2.17
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 2.01
Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin (2009) 1.57
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol (2000) 1.50
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm (Vienna) (2010) 1.22
The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health (2003) 1.20
Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology (2008) 1.17
Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol (2008) 1.13
Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol (2009) 1.12
Nanotechnology-novel therapeutics for CNS disorders. Nat Rev Neurol (2012) 1.05
Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J Neurosci (2012) 1.05
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci (2010) 1.01
Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiol Dis (2014) 1.00
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. Dis Model Mech (2011) 1.00
Oxidative stress in genetic mouse models of Parkinson's disease. Oxid Med Cell Longev (2012) 0.98
A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response. Trends Mol Med (2013) 0.96
Oxidative stress and microglial cells in Parkinson's disease. Mediators Inflamm (2012) 0.96
Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxid Med Cell Longev (2012) 0.96
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease. Curr Neuropharmacol (2007) 0.94
A FRET-based method to study protein thiol oxidation in histological preparations. Free Radic Biol Med (2008) 0.91
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity. Synapse (2009) 0.90
Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. J Pharmacol Exp Ther (2008) 0.90
Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology (2008) 0.90
Cutting edge: IL-13Rα1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J Immunol (2012) 0.89
Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease. Parkinsons Dis (2011) 0.89
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Cell Mol Neurobiol (2007) 0.89
1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons. Toxicol Appl Pharmacol (2007) 0.88
Long-term effects of ionising radiation on the brain: cause for concern? Radiat Environ Biophys (2012) 0.86
Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells. BMC Neurosci (2010) 0.85
Nitric oxide and MPP+-induced hydroxyl radical generation. J Neural Transm (Vienna) (2006) 0.85
Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans. Int J Mol Sci (2013) 0.85
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. J Neural Transm (Vienna) (2007) 0.85
Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo. PLoS One (2013) 0.84
Region-specific effects on brain metabolites of hypoxia and hyperoxia overlaid on cerebral ischemia in young and old rats: a quantitative proton magnetic resonance spectroscopy study. J Biomed Sci (2010) 0.84
Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. Cell Mol Neurobiol (2010) 0.84
Effects of chronic low dose rotenone treatment on human microglial cells. Mol Neurodegener (2009) 0.83
A role of fluoride on free radical generation and oxidative stress in BV-2 microglia cells. Mediators Inflamm (2012) 0.82
Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice. PLoS One (2012) 0.82
Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Ann N Y Acad Sci (2008) 0.82
Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output. Neurotoxicology (2011) 0.81
Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain. J Neural Transm (Vienna) (2010) 0.80
Early-life exposure to methylmercury in wildtype and pdr-1/parkin knockout C. elegans. Neurochem Res (2013) 0.80
Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol (2008) 0.80
PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target. Neurotox Res (2013) 0.80
Ginkgo biloba extract in an animal model of Parkinson's disease: a systematic review. Curr Neuropharmacol (2013) 0.79
A phenotypic model recapitulating the neuropathology of Parkinson's disease. Brain Behav (2013) 0.79
GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways. Int J Mol Sci (2016) 0.79
Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria. Arch Toxicol (2015) 0.79
Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation. Autophagy (2015) 0.79
Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neurons. Neuroscience (2014) 0.78
Nutraceuticals in Parkinson's Disease. Neuromolecular Med (2016) 0.76
Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease. Neurotox Res (2014) 0.75
Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves. Adv Pharmacol Sci (2016) 0.75
Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases. Mediators Inflamm (2017) 0.75
Red Lentil Extract: Neuroprotective Effects on Perphenazine Induced Catatonia in Rats. J Clin Diagn Res (2016) 0.75
Parkinson's disease: genetics and beyond. Curr Neuropharmacol (2007) 0.75
Phosphatidylinositol transfer protein expression altered by aging and Parkinson disease. Cell Mol Neurobiol (2006) 0.75
Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases. PLoS One (2017) 0.75